Bixiye
Verkazia® - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1501 - 1510 ee natiijooyinka 3289
Bixiye
Eohilia - Medicaid
Prior Authorization
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors and Combinations - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
Benign Prostatic Hypertrophy (BPH) - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker (Corlanor) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
ARB/Renin Inhibitors - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
Proton Pump Inhibitors (PPIs) - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Bixiye
QP73-24 Prime Therapeutics/Magellan Rx Management (medical pharmacy solutions program) to become “Prime Therapeutics Management”
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2024
Bixiye
QP71-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024
Bixiye
QP72-24 Provider Survey being Conducted by the Minnesota Department of Human Services (DHS)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2024